社債
以下は、最終利回り順に並べたAbbVie Inc.の債券のリストです。市場のボラティリティが高い時期には、安定性を求めて社債が選好される傾向にあります。価格や利回りなどの統計データを確認し、信頼できる投資先を見つけましょう。
シンボル | YTM % | 出来高 | 価格 % | クーポン % | 満期日 | 発行残高 | 額面金額 | 最低額面 | 発行体 |
|---|---|---|---|---|---|---|---|---|---|
| AACT4218883Allergan Funding SCS 4.75% 15-MAR-2045 | 7.00% | 26 K | 76.04% | 4.750% | 2045-03-15 | 53.51 M USD | 1,000.00 USD | 2,000.00 USD | Allergan Funding SCS |
| AACT4176286Allergan Funding SCS 4.85% 15-JUN-2044 | 6.40% | 12 K | 83.25% | 4.850% | 2044-06-15 | 65.23 M USD | 1,000.00 USD | 2,000.00 USD | Allergan Funding SCS |
| AACT3910526Actavis, Inc. 4.625% 01-OCT-2042 | 6.38% | 124 K | 81.98% | 4.625% | 2042-10-01 | 67.49 M USD | 1,000.00 USD | 2,000.00 USD | Actavis, Inc. |
| AACT4218882Allergan Funding SCS 4.55% 15-MAR-2035 | 5.79% | 250 K | 91.22% | 4.550% | 2035-03-15 | 107.65 M USD | 1,000.00 USD | 2,000.00 USD | Allergan Funding SCS |
| 5.57% | 525 K | 98.20% | 5.400% | 2054-03-15 | 3 B USD | 1,000.00 USD | 2,000.00 USD | AbbVie, Inc. | |
| 5.55% | 3.4 M | 101.14% | 5.600% | 2055-03-15 | 750 M USD | 1,000.00 USD | 2,000.00 USD | AbbVie, Inc. | |
| 5.55% | 845 K | 91.65% | 4.875% | 2048-11-14 | 1.75 B USD | 1,000.00 USD | 2,000.00 USD | AbbVie, Inc. | |
| 5.53% | 1.05 M | 91.58% | 4.750% | 2045-03-15 | 827.09 M USD | 1,000.00 USD | 2,000.00 USD | AbbVie, Inc. | |
| 5.53% | 305 K | 83.28% | 4.250% | 2049-11-21 | 5.75 B USD | 1,000.00 USD | 2,000.00 USD | AbbVie, Inc. | |
| 5.53% | 99 K | 97.65% | 5.500% | 2064-03-15 | 1.5 B USD | 1,000.00 USD | 2,000.00 USD | AbbVie, Inc. | |
| 5.52% | 0 | 86.96% | 4.450% | 2046-05-14 | 2 B USD | 1,000.00 USD | 2,000.00 USD | AbbVie, Inc. | |
| 5.49% | 26 K | 90.47% | 3.200% | 2029-11-21 | 62.52 M USD | 1,000.00 USD | 2,000.00 USD | AbbVie, Inc. | |
| 5.48% | 0 | 90.71% | 4.700% | 2045-05-14 | 2.7 B USD | 1,000.00 USD | 2,000.00 USD | AbbVie, Inc. | |
| 5.45% | 1 M | 93.28% | 4.850% | 2044-06-15 | 1.01 B USD | 1,000.00 USD | 2,000.00 USD | AbbVie, Inc. | |
| 5.45% | 2.2 M | 99.06% | 5.350% | 2044-03-15 | 750 M USD | 1,000.00 USD | 2,000.00 USD | AbbVie, Inc. | |
| 5.38% | 2 M | 91.95% | 4.625% | 2042-10-01 | 389.22 M USD | 1,000.00 USD | 2,000.00 USD | AbbVie, Inc. | |
| 5.33% | 0 | 89.67% | 4.400% | 2042-11-06 | 2.6 B USD | 1,000.00 USD | 2,000.00 USD | AbbVie, Inc. | |
| 5.15% | 631 K | 89.30% | 4.050% | 2039-11-21 | 4 B USD | 1,000.00 USD | 2,000.00 USD | AbbVie, Inc. | |
| 4.96% | 0 | 93.99% | 2.625% | 2028-11-15 | 72.11 M EUR | 1,000.00 EUR | 100,000.00 EUR | Allergan Funding SCS | |
| 4.85% | 0 | 95.53% | 4.300% | 2036-05-14 | 1 B USD | 1,000.00 USD | 2,000.00 USD | AbbVie, Inc. | |
| 4.79% | 850 K | 103.37% | 5.200% | 2035-03-15 | 1 B USD | 1,000.00 USD | 2,000.00 USD | AbbVie, Inc. | |
| 4.78% | 0 | 97.92% | 4.500% | 2035-05-14 | 2.5 B USD | 1,000.00 USD | 2,000.00 USD | AbbVie, Inc. | |
| 4.77% | 410 K | 98.38% | 4.550% | 2035-03-15 | 1.68 B USD | 1,000.00 USD | 2,000.00 USD | AbbVie, Inc. | |
| 4.67% | 29 K | 102.78% | 5.050% | 2034-03-15 | 3 B USD | 1,000.00 USD | 2,000.00 USD | AbbVie, Inc. | |
| 4.26% | 68 K | 103.17% | 4.950% | 2031-03-15 | 2 B USD | 1,000.00 USD | 2,000.00 USD | AbbVie, Inc. | |
| 4.14% | 438 K | 102.82% | 4.875% | 2030-03-15 | 1 B USD | 1,000.00 USD | 2,000.00 USD | AbbVie, Inc. | |
| 4.11% | 6.7 M | 96.84% | 3.200% | 2029-11-21 | 5.44 B USD | 1,000.00 USD | 2,000.00 USD | AbbVie, Inc. | |
| 4.02% | 50 K | 102.42% | 4.800% | 2029-03-15 | 2.5 B USD | 1,000.00 USD | 2,000.00 USD | AbbVie, Inc. | |
| 3.98% | 0 | 99.77% | 3.200% | 2026-05-14 | 2 B USD | 1,000.00 USD | 2,000.00 USD | AbbVie, Inc. | |
| 3.94% | 265 K | 100.92% | 4.250% | 2028-11-14 | 1.75 B USD | 1,000.00 USD | 2,000.00 USD | AbbVie, Inc. | |
| 3.88% | 2.81 M | 101.03% | 4.800% | 2027-03-15 | 2.25 B USD | 1,000.00 USD | 2,000.00 USD | AbbVie, Inc. | |
| 3.85% | 15.13 M | 101.55% | 4.650% | 2028-03-15 | 1.25 B USD | 1,000.00 USD | 2,000.00 USD | AbbVie, Inc. | |
| 3.84% | 913 K | 99.30% | 2.950% | 2026-11-21 | 3.99 B USD | 1,000.00 USD | 2,000.00 USD | AbbVie, Inc. | |
| XXS162262122Allergan Funding SCS 2.125% 01-JUN-2029 | 3.74% | 0 | 94.99% | 2.125% | 2029-06-01 | 36.46 M EUR | 1,000.00 EUR | 100,000.00 EUR | Allergan Funding SCS |
| 3.16% | 0 | 126.76% | 4.750% | 2045-03-15 | 5 K USD | 1,000.00 USD | 2,000.00 USD | AbbVie, Inc. | |
| 3.13% | 0 | 128.71% | 4.850% | 2044-06-15 | 100 K USD | 1,000.00 USD | 2,000.00 USD | AbbVie, Inc. | |
| 3.13% | 0 | 121.31% | 4.250% | 2049-11-21 | 4.95 M USD | 1,000.00 USD | 2,000.00 USD | AbbVie, Inc. | |
| 3.08% | 0 | 90.35% | 1.250% | 2031-11-18 | 650 M EUR | 1,000.00 EUR | 100,000.00 EUR | AbbVie, Inc. | |
| 2.69% | 0 | 98.19% | 2.125% | 2029-06-01 | 506.09 M EUR | 1,000.00 EUR | 100,000.00 EUR | AbbVie, Inc. | |
| 2.62% | 0 | 100.02% | 2.625% | 2028-11-15 | 427.79 M EUR | 1,000.00 EUR | 100,000.00 EUR | AbbVie, Inc. | |
| 2.57% | 0 | 123.74% | 4.550% | 2035-03-15 | 1 K USD | 1,000.00 USD | 2,000.00 USD | AbbVie, Inc. | |
| 2.52% | 0 | 98.92% | 2.125% | 2028-11-17 | 750 M EUR | 1,000.00 EUR | 100,000.00 EUR | AbbVie, Inc. | |
| 2.40% | 0 | 97.10% | 0.750% | 2027-11-18 | 750 M EUR | 1,000.00 EUR | 100,000.00 EUR | AbbVie, Inc. | |
| −5.92% | 0 | 98.80% | 2.950% | 2026-11-21 | 9.24 M USD | 1,000.00 USD | 2,000.00 USD | AbbVie, Inc. | |
| — | — | — | 4.400% | 2042-11-06 | 1.1 M USD | 1,000.00 USD | 2,000.00 USD | AbbVie, Inc. |